Forward-Looking Statement

This website and other statements that Astex Pharmaceuticals™ may make may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to Astex Pharmaceuticals' future financial or business performance, strategies or expectations.

Forward-looking statements are typically identified by words or phrases such as "trend," "potential," "opportunity," "pipeline," "believe," comfortable," "expect," "anticipate," "current," "intention," "estimate," "position," "assume," "outlook," "continue," "remain," "maintain," "sustain," "seek," "achieve," and similar expressions, or future or conditional verbs such as "will," "would," "should," "could," "may," or similar expressions.

Astex Pharmaceuticals cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change overtime. Forward-looking statements speak only as of the date they are made, and Astex Pharmaceuticals assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

In addition to factors previously disclosed in Astex Pharmaceuticals’ SEC reports and those identified elsewhere on this website, the following factors, among others, could cause actual result to differ materially from forward-looking statements or historical performance: (1) the success of drug development efforts; (2) our cash and prospective financial positions; (3) the ability of Astex Pharmaceuticals to realize the benefits of the transaction with Astex Therapeutics, Ltd.; (4) the achievement of regulatory approvals in the US and abroad; (5) the success of partnerships to develop and sell drugs in the US and abroad; (6) our ability to develop and commercialize new drugs; (7) the impact of increased competition; (8) the impact of future acquisitions or divestitures; (9) the adequacy of intellectual property protection; (10) the impact of legislative and regulatory actions and regulatory, supervisory or enforcement actions of government agencies; and (11) the ability to attract and retain highly talented professionals.

Astex Pharmaceuticals’ Annual Reports on Form 10-K and Astex Pharmaceuticals’ subsequent reports filed with the SEC, accessible on the SEC's website at and on this site, discuss these factors in more detail and identify additional factors that can affect forward-looking statements.